Nuzenio

Phio Pharmaceuticals Reports

Phio Pharmaceuticals Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Timeline

Thu, 06 Aug 2026 20:36:00 GMTPhio Pharmaceuticals Corp. Q2 2026: Net income $(4.14)M, EPS $(0.36) — 10-Q Summary - TradingView
Thu, 06 Aug 2026 20:35:16 GMTPhio Pharmaceuticals posts $4.1M Q2 net loss, cash $13.0M; advances PH-762 program - TradingView
Thu, 06 Aug 2026 20:18:30 GMTPHIO: Q2 2026 net loss widened to $4.1M as PH-762 advanced, with $13M in cash and ongoing funding needs - TradingView
Thu, 06 Aug 2026 20:05:00 GMTPhio intends to request an FDA meeting after 22-patient cancer study - Stock Titan
Tue, 28 Jul 2026 07:00:00 GMTPhio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series - newsfilecorp.com

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Phio Pharmaceuticals Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.